Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET
KISQALI is proven to help reduce the risk of cancer coming back*
*KISQALI + an aromatase inhibitor (AI) cut the risk of cancer returning by 25% compared to an AI alone. At 3 years, 91% of people taking KISQALI + AI were cancer-free, compared with 88% of people taking an AI alone.
For patients like you with early breast cancer, consider KISQALI + an AI
Watch Maya's story to see how reducing the risk of your cancer returning can mean more to live for.*